miR-129-5p improves cardiac function in rats with chronic heart failure through targeting HMGB1
- 64 Downloads
Increasing evidence shows that miRNAs play pivotal roles in cardiovascular diseases, including heart failure (HF). The aim of this study was to investigate the role of miR-129-5p in chronic heart failure and the underlying mechanisms. The levels of miR-129-5p and HMGB1 in chronic heart failure patients (CHF) and normal controls were examined by RT-qPCR and ELISA. Cardiac function, hemodynamics parameters, oxidative stress, and inflammation factors were analyzed in CHF rat model after transfection of miR-129-5p or HMGB1. Dual-luciferase activity reporter assay was conducted to validate the interaction between miR-129-5p and HMGB1. Downregulation of miR-129-5p and upregulation of HMGB1 were observed in the serum of CHF patients, respectively. Transfection of miR-129-5p improved heart function and hemodynamic parameters, as well as attenuated oxidative stress and inflammation factors in CHF rats. We further confirmed that HMGB1 is a direct target of miR-129-5p. Transfection of miR-129-5p also decreased the mRNA and protein levels of HMGB1 in myocardial tissues of CHF rats. Overexpression of HMGB1 diminished the effects of miR-129-5p on ameliorating oxidative stress and inflammatory response in rats with CHF. Our findings suggest that miR-129-5p protects the heart by targeting HMGB1.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All participants in this study were informed and gave a written consent.
Research involving human participants and/or animals
The protocols were approved by the Ethics Committee of Cangzhou Central Hospital, and all participants signed informed consent.
- Azad N, Lemay G (2014) Management of chronic heart failure in the older population. J Geriatr Cardiol 11:329–337. https://doi.org/10.11909/j.issn.1671-5411.2014.04.008 CrossRefPubMedPubMedCentralGoogle Scholar
- Li XQ, Chen FS, Tan WF, Fang B, Zhang ZL, Ma H (2017) Elevated microRNA-129-5p level ameliorates neuroinflammation and blood-spinal cord barrier damage after ischemia-reperfusion by inhibiting HMGB1 and the TLR3-cytokine pathway. J Neuroinflamm 14:205. https://doi.org/10.1186/s12974-017-0977-4 CrossRefGoogle Scholar
- Ramachandran S, Lowenthal A, Ritner C, Lowenthal S, Bernstein HS (2017) Plasma microvesicle analysis identifies microRNA 129-5p as a biomarker of heart failure in univentricular heart disease. PLoS ONE 12:e0183624. https://doi.org/10.1371/journal.pone.0183624 CrossRefPubMedPubMedCentralGoogle Scholar
- Rock KL, Kono H (2008) The inflammatory response to cell death. Annu Rev Pathol 3:99–126. https://doi.org/10.1146/annurev.pathmechdis.3.121806.151456 CrossRefPubMedPubMedCentralGoogle Scholar
- Voellenkle C et al (2010) MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genom 42:420–426. https://doi.org/10.1152/physiolgenomics.00211.2009 CrossRefGoogle Scholar